Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Interactions of Serotonin Reuptake Inhibitors With Tricyclic Antidepressants-Reply

Anand Popli, MD; Ross J. Baldessarini, MD; Jonathan O. Cole, MD
Arch Gen Psychiatry. 1995;52(9):784-785. doi:10.1001/archpsyc.1995.03950210078015.
Text Size: A A A
Published online


In reply  Harvey and Preskorn are to be commended for their efforts to predict the degree of in vivo interaction of SSSRIs with other agents at human hepatic microsomal enzymes of the CYP oxidase family, which is critical for the metabolic clearance of drugs and other xenobiotic molecules. Their models are based on in vitro characterizations of liver-plasma parBased on recent reviews by De Vane and Preskorn.8 SSRI indicates selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; FVX, fluvoxamine; FLX, fluoxetine; SRT, sertraline; PRX, paroxetine, NORFLX, norfluoxetine; VNX, venlafaxine; and NFZ, nefazodone.•Secondary-amine TCAs include desipramine and tertiary-amine TCAs include amitryptyline. Neuroleptics include phenothiazines, clozapine, haloperidol, and risperidone.•Inducers of increased oxidase activity include carbamazepine.§ Possible CYP enzyme inhibitors. tition coefficients and normalized Kis of SSRIs and yield plausible results. Nevertheless, several caveats and points of agreement concerning the state of knowledge on this topic need to be reemphasized.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.